Procurement Summary
Country: USA
Summary: Hive 20 Expansion of Fda Argos
Deadline: 02 Jul 2026
Posting Date: 18 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143512695
Document Ref. No.: 75F40125C00095
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Title: Hive 2.0: Expansion of FDA ARGOS (database for Reference Grade micrObial Sequences)
Agency: U.S. Food and Drug Administration (FDA) Notice Type: Presolicitation: Cost Reimbursement
The U.S. Food and Drug Administration (FDA) intends to modify, on a sole source basis (in accordance with FAR 6.103-1), contract #75F40125C00095 with DNA HIVE, 3909 Fox Valley Drive, Rockville, MD 20853. The North American Industry Classification System (NAICS) code is 541714- Research and Development in Biotechnology (except Nanobiotechnology). The modification will not alter the existing period of performance established under the contract.
Under this sole source modification, the contractor shall provide research and development services (including, but not limited to, biological and bioinformatic research) to expand the current repository of genetic sequence information under the ARGOS database.
As such, this modification does not add new tasks, but rather expands on current tasks, specifically:
Aim-1: Deployment, configuration, launch ARGOS instance running on a newer version of H2O
Aim-2: Develop, adopt, and deploy AI and NGS Bioinformatics tools for:
Aim-2.1: evaluation of epigenetic based pathogen detection diagnostics products for Lyme disease.
Aim-2.2: assembly of new virus genomes for ARGOS using bulk public health sequencing datasets
Aim-2.3: evaluation of emerging pathogens.
Aim-2.4: predictive toxicology.
Aim-2.5: evaluation of food import safety.
Aim-2.6: on-, of-target evaluation of gene editing products.
Aim-2.7: evaluation of biologics manufacturing consistency.
Aim-2.8: evaluation of efficacy of attenuated vaccine and life viral products.
Aim-3: Deliver regulatory grade high-quality reference datasets.
Aim-3.1: Continuing to support FDA-ARGOS project with pathogen reference datasets.
Aim-3.2: Continuing to support epigenetic biomarker datasets for FDA.
Aim-4: Integrate FDA into ARPA-H FEAST network to provide...
Notice ID: 75f40125c00095
Department/Ind. Agency: health and human services, department of
Sub-tier: food and drug administration
Office: fda office of acq grant svcs
Product Service Code: an11 - health r&d services; health care services; basic research
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Inactive Dates: jul 17, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice